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The ability to engineer genomes in a specific, systematic, and cost-
effective way is critical for functional genomic studies. Recent
advances using the CRISPR-associated single-guide RNA system
(Cas9/sgRNA) illustrate the potential of this simple system for ge-
nome engineering in a number of organisms. Here we report an
effective and inexpensive method for genome DNA editing in
Drosophila melanogaster whereby plasmid DNAs encoding short
sgRNAs under the control of the U6b promoter are injected into
transgenic flies in which Cas9 is specifically expressed in the germ
line via the nanos promoter. We evaluate the off-targets associ-
ated with the method and establish a Web-based resource, along
with a searchable, genome-wide database of predicted sgRNAs
appropriate for genome engineering in flies. Finally, we discuss
the advantages of our method in comparison with other recently
published approaches.
nanos-Cas9 | HRMA
Much of our knowledge of the mechanisms underlying bi-ological processes relies on genetic approaches, whereby
gene activity is perturbed and the phenotypic consequences of
perturbation are analyzed in detail. In recent years, several major
advances have been made in the design of methods for specifi-
cally and efficiently perturbing genomes. Arguably, the most
exciting advances rely on the ability to induce double-strand
breaks (DSBs) by targeting a nuclease to a specific genomic se-
quence. Repair of DSBs by the error-prone nonhomologous end-
joining (NHEJ) mechanism allows for the recovery of small dele-
tions; moreover, repair of DSBs by homologous recombination
(HR) in the presence of a donor template opens the door to a wide
range of specifically engineered changes at the targeted site (1).
Two nuclease-based systems, the zinc-finger nuclease (ZFN)
and transcription activator-like effector nuclease (TALEN) sys-
tems, work effectively in a number of organisms (2–7). But be-
cause these approaches require the production of a construct
encoding a unique DNA-binding protein fused to the nuclease
domain, they can be both cumbersome and costly. In contrast, the
recent approach based on the bacterial CRISPR- associated sin-
gle-guide RNA (Cas9/sgRNA) system does not require production
of specific fusion proteins for each targeted sequence (8–10).
Cas9 was first identified in type II Streptococcus pyogenes as an
RNA-guided defense system against invading viruses and plas-
mids (11–13). This adaptive immune-like system contains three
components: CRISPR RNA (crRNA), trans-activating CRISPR
RNA (tracrRNA), and Cas9. The tracrRNA triggers Cas9 nuclease
activity and the crRNA guides Cas9 to cleave the specific foreign
dsDNA sequence via base-pairing between the crRNA and the
target DNA. Importantly, a single-guide RNA (sgRNA, also known
as chiRNA), comprising the minimal crRNA and tracrRNA, can
function similarly to the crRNA and tracrRNA, thereby providing
a simplified method for genome editing (8–10, 14–20).
Given the great promise of the Cas9/sgRNA method for ge-
nome engineering, we set out to test the system in Drosophila
melanogaster. Although many genomic engineering tools are al-
ready available for Drosophila (21, 22), including ZFNs and
TALENs (2–7), we reasoned that the Cas9/sgRNA system might
provide a more cost-effective approach, allowing its use at a ge-
nome scale. Similar to other recent reports (14, 16, 20), we found
that the Cas9/sgRNA system works in Drosophila. Moreover, we
found that injection of sgRNAs into a transgenic line expressing
Cas9 in the germ line (nanos-Cas9) provides a straightforward,
effective, and inexpensive method that can facilitate the pro-
duction of large mutant collections. We also evaluated the
frequency of off-target events associated with Cas9/sgRNA. In
addition, to facilitate prediction and testing of off-target events,
we established a searchable database of in silico predicted sgRNAs
that includes information about predicted off-target events. Fi-
nally, we compared our approach with methodologies recently
reported by others (14, 16, 20).
Results
Optimization of the Cas9/sgRNA System. To test the efficacy of
the Cas9/sgRNA system in inducing germ-line mutations in
D. melanogaster, we generated a vector that expresses the Cas9
gene under the nanos (nos) promoter (Fig. 1A). We reasoned
that the nos promoter would induce strong and restricted ex-
pression of the transgene in germ cells, which might help avoid
Significance
Using the recently introduced Cas9/sgRNA technique, we have
developed a method for specifically targeting Drosophila germ-
line cells to generate heritable mutant alleles. We have estab-
lished transgenic lines that stably express Cas9 in the germ line
and compared different promoters and scaffolds of sgRNA in
terms of their efficiency of mutagenesis. An overall mutagen-
esis rate of 74.2% was achieved with this optimized system, as
determined by the number of mutant progeny out of all prog-
eny screened. We also evaluated the off-targets associated
with the method and established a Web-based resource, as
well as a searchable, genome-wide database of predicted
sgRNAs appropriate for genome engineering in flies. Our
results demonstrate that this optimized Cas9/sgRNA system in
Drosophila is efficient, specific, and cost-effective and can be
readily applied in a semi-high-throughput manner.
Author contributions: J. Xu, N.P., and J.-Q.N. designed research; X.R., J.S., B.E.H., L.-P.L.,
Z.Y., D.M., L.S., Q.W., J. Xu, N.P., and J.-Q.N. performed research; Y.H., C.R., S.L., J.-Y.J.,
and J. Xi contributed new reagents/analytic tools; X.R., J.S., B.E.H., L.-P.L., Z.Y., D.M., L.S.,
Q.W., J. Xu, and J.-Q.N. analyzed data; and S.E.M., J. Xu, N.P., and J.-Q.N. wrote the paper.
The authors declare no conflict of interest.
1X.R. and J.S. contributed equally to this work.
2To whom correspondence may be addressed. E-mail: jiangxu@mail.tsinghua.edu.cn,
perrimon@receptor.med.harvard.edu, or nijq@mail.tsinghua.edu.cn.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1318481110/-/DCSupplemental.
19012–19017 | PNAS | November 19, 2013 | vol. 110 | no. 47 www.pnas.org/cgi/doi/10.1073/pnas.1318481110
viability issues associated with disruption of essential genes in the
surrounding somatic cells. The nos-Cas9 DNA was coinjected
with U6b-sgRNA DNA targeting the white (w) gene (Fig. 1B). We
initially used the U6b core promoter, which has been shown to be
an effective promoter in both mammals and Drosophila.With the
nos-Cas9 DNA and a single sgRNA plasmid combination, white-
eyed mutants were recovered at an overall heritable mutation
rate as high as 2.7% (i.e., the percentage of mutant F1s out of all
F1s screened) (Table 1).
We next compared the efficiencies of different promoters in
controlling the transcription of sgRNA (Fig. 1B). We tested
whether a different U6 promoter, the U6a promoter, could lead
to higher expression levels of sgRNA. We also tested a modified
nos promoter (Materials and Methods), with the idea that this
promoter should allow for high expression of sgRNAs specifi-
cally in germ-line cells. We also note that unlike the sgRNAs
associated with the U6 promoters, those used in conjunction with
the nos cassette also include 5′ and 3′ UTR sequences and
should be transcribed by RNA polymerase II.
Based on the frequency of mutations recovered (Table 2), U6b
was the most effective of the three promoters tested. Given
previous in vitro studies suggesting that crRNA-tracrRNA
duplexes with extra nucleotides lead to increased efficiency of
genome editing (9), we next constructed a version of the sgRNA
cassette with additional nucleotides inserted between the crRNA
and tracrRNA to extend the sgRNA further than those previously
tested (Fig. 1C). A comparison of two sgRNAs targeting w revealed
that the shorter version was approximately twice as effective as the
longer version (Table 2); thus, we used the short version in all
subsequent constructs. Taken together, our results show that Cas9,
expressed under the control of nos regulatory sequence, along with
a short sgRNA under the control of U6b appears to provide an
optimal combination for genome editing in Drosophila.
Transgenic Expression of Cas9 in the Germ Line Results in Dramatically
Increased Efficiency of Mutagenesis. We reasoned that the effi-
ciency of mutagenesis and recovery of injected animals might be
compromised by transient expression of Cas9 after DNA in-
jection, variation in the developmental stage of the injected
embryos, and/or DNA concentration. With the idea of circum-
venting these potential issues, we hypothesized that expression of
Cas9 in the germ cells via a transgene might improve the effi-
ciency of mutagenesis after injection of sgRNAs into these
transgenic flies. We made use of the fact that our nos-Cas9
vector contains an attB sequence and the vermilion reporter gene
(Fig. 1A), and generated transgenic fly strains in which nos-Cas9
was integrated into either the attP40 site on chromosome 2 or
the attP2 site on chromosome 3. Both transgenic fly stocks are
healthy and fertile, and expression of the Cas9 transcript was
readily detected by RT-PCR (Fig. 2B).
To test the Cas9/sgRNA system with these transgenic animals,
we next injected {nos-Cas9}attP2 fly embryos with w1 sgRNA
and/or w2 sgRNA targeting the w gene. Specifically, the sgRNAs
were injected individually to generate mutations by NHEJ or
injected together to generate a 3.2-kb deletion (Fig. 2A). Strik-
ingly, the overall heritable mutation rates reached 42.9% for w1
and 12.4% for w2, which are significantly higher than the 2.7%
and 0.6% obtained after coinjection of nos-Cas9 and w1 or w2
sgRNA DNAs, respectively (Tables 1 and 3). Note that ap-
proximately 25% of embryos from either coinjection of Cas9/
sgRNA DNA or injection of sgRNA DNA into {nos-Cas9}attP2
embryos developed into fertile adults, indicating no apparent
toxicity associated with either method (Tables 1 and 3).
To examine whether these mutations also could be detected
in G0 animals, we amplified the targeted region from whole
embryo genomic DNA. Using high-resolution melt analysis
(HRMA), we were able to detect mutations, facilitating iso-
lation of effective mutations at an early stage (Materials and
Methods). Of 15 G0 animals tested, 5 contained mutations at
w1 but none had mutations at w2, likely owing to the lower
mutagenesis rate of w2 (Table S1).
Injection of the two w sgRNAs together generated deletions
between the targets and improved the overall heritable mutation
rate significantly (74.2% with w1 + w2, compared with 42.9%
with w1 and 12.4% with w2) (Table 3). Random testing of 30
white-eyed F1 flies from six G0 lines identified defined sets of
deletion mutations in 16 progeny derived from five individual G0
flies, for example, 74.2% with w1 + w2, 53% of which were 3.2-
kb deletions. Importantly, defined genomic deletions resulting
after the introduction of two different sgRNAs could be readily
identified in the F1 flies by PCR amplification. Furthermore,
PCR identified 5 of 21 G0 adult flies with defined deletions. In
conclusion, generation of deletions using two sgRNAs not only
increased the efficiency of mutagenesis, but also facilitated de-
tection of deletion events in G0 flies.
Off-Target Analysis. Previous studies have shown that a single
mismatch between the sgRNA and the target DNA outside the
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Fig. 1. Optimization of the Drosophila Cas9/sgRNA system. (A) The nos-Cas9
plasmid encodes the S. pyogenes Cas9 gene under the regulation of the nos
promoter 5′ UTR and 3′ UTR. The attB sequence and a vermillion+ marker
are also included in this plasmid. This plasmid was used either directly for
mutagenesis in microinjection experiments or for insertion into attP sites to
generate Cas9 transgenic flies. (B and C) Schematics of the sgRNA constructs
used in this study. (B) Three versions of plasmids expressing sgRNA (U6a,
U6b, or minimal nos promoter). (C) Two sgRNA scaffold versions, one similar
to that described by Mali et al. (10) and the other with 10 extra base pairs
inserted between the crRNA and the tracrRNA modules. The extra base pairs
are underscored.
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13-nt neighboring protospacer adjacent motif (PAM), the so-
called “seed” region, can be tolerated, given that sgRNA with
a single mismatch in nucleotides 14–20 can still guide Cas9 to
introduce DSB in the genome (8–10, 23). Furthermore, Cas9 can
induce a DSB at genomic sequences with as many as five nu-
cleotide mismatches to the sgRNA (18, 24). To evaluate the
potential off-target events associated with w1 and w2 sgRNAs, we
identified all possible locations that share high sequence similarity
with the target site and include a PAM sequence (see Online Re-
source of sgRNA Designs for Drosophila Genome Editing and Fig. 3).
The tool did not identify any off-target sequences using default
conditions, but when search criteria were relaxed, 10 potential off-
target sites were found (five for each sgRNA), with the closest
match containing six mismatches to the on-target sequence (Fig. 3).
We next PCR-amplified the potential off-target regions from
genomic DNA of white-eyed F1 flies with defined deletions
generated by injection of both w1 and w2 sgRNAs and assayed
for the presence of mutations using HRMA or sequencing. Using
HRMA, we analyzed eight independent F1 adult flies for each
sgRNA and failed to detect any mutations at any of these sites
(Table S1). Finally, we sequenced 20 cloned PCR products from
each of eight F1 adults per off-target site and did not detect any
mutations, further confirming the HRMA results (Fig. S1).
Online Resource of sgRNA Designs for Drosophila Genome Editing. To
facilitate the use of sgRNAs in Drosophila, we established a freely
available online resource of precomputed sgRNAs (www.flyrnai.
org/crispr). We developed the resource in two steps. We first
extracted all possible 23mers from both the forward and reverse
strands of the genomic sequence of D. melanogaster based on
FlyBase release 5.52 (July 15, 2013). Some 7.6 million of these
23mers end with a PAM sequence (NGG) and have a unique 15-
bp sequence, which includes the seed region sequence and PAM
sequence, in the genome. We selected this subset of 23mers as
potential CRISPR sgRNA designs and aligned them to the ge-
nome sequence. We found that 28% of these sgRNA sequences
aligned to intergenic regions, 37% aligned to introns, and 35%
targeted the exon region of annotated genes [coding sequence
(CDS) or noncoding regions; Table 4].
We next systematically analyzed potential off-target sites,
which share a certain level of sequence similarity (up to five
mismatches) and end with a PAM sequence (NGG), for each
CRISPR sgRNA design. Although the presence of the NGG
PAM sequence on the genomic DNA is required for Cas9 rec-
ognition, variations in the PAM (e.g., NAG) can be tolerated in
bacteria (18, 24); thus, to be cautious, in the off-target analysis
we also included the sites ending with NAG. We found that for
CRISPR sgRNA designs targeting gene CDS regions within
exons, 104,892 (5% of all designs targeting CDS) have no pre-
dicted off-targets, whereas 506,998 (24%) have no predicted off-
targets in CDS regions of other genes (Table 4). The designs that
target a CDS and have no predicted off-targets correspond to
11,950 Drosophila genes (i.e., 86% coverage of protein-coding
genes). Together, the 611,890 designs that target a CDS and have
no predicted off-targets in another CDS correspond to 12,996
protein-coding genes (93% coverage of protein-coding genes).
To make the designs available, we developed a user interface
that allows the community to query all relevant CRISPR designs
by gene identifier (gene symbol, CG number, or FBgn) or ge-
nome coordinates and to view all corresponding sgRNA designs
on a genome browser (Fig. S2). To identify CRISPR sgRNAs
targeting intergenic regions, such as promoters, users can enter
an identifier corresponding to a nearby gene, then use the nav-
igator to find the intergenic region of interest, or can enter ge-
nome coordinates directly. To help users select relevant designs,
CRISPR sgRNAs with different predicted properties regarding
the target region and potential off-targets are separated into
different tracks, for example “CRISPRs target CDS region/
without any off-target” and “CRISPRs target intron/without any
off-target.” By clicking on the sgRNA of interest at the genome
browser, the user can access detailed information, such as se-
quence and potential off-target genes (Fig. S2).
Discussion
We report a simple and effective method for efficiently gener-
ating heritable loss-of-function alleles in D. melanogaster using
the Cas9/sgRNA system. Specifically, we show that injection of
sgRNAs into a transgenic line that expresses Cas9 in the germ
line (nos-Cas9) is an effective and relatively inexpensive tech-
nique for genome engineering.
Several recent studies also have reported success in using the
Cas9/sgRNA system to edit genomic DNA in Drosophila (14,
Table 1. Heritable mutation rates using nos-Cas9 and sgRNA plasmids
G0 adults
Overall heritable mutation rate
(individual), %, median (range)†sgRNA Embryos, n Total n Survival rate, % Fertile, n
Germ-line
mutants, n (%)*
w1 65 14 21.5 13 4 (30.8) 2.7 (3.1–15.1)
w2 60 15 25.0 13 3 (23.1) 0.6 (1.2–3.2)
*The percentage of germ-line mutants was calculated as the proportion of fertile G0 flies that gave rise to white-eyed progeny.
†The overall heritable mutation rate was calculated as the number of white-eye F1s divided by the number of all F1s observed. Mutation rates for each G0 fly that
generated white-eyed progeny are shown in parentheses and are calculated as the number of white-eyed F1s divided by the total F1s observed from a single G0 fly.
Table 2. Heritable mutation rates using nos-Cas9 and different sgRNA plasmid constructs
SgRNA
promoter
sgRNA
scaffold Embryos, n
G0 adults
Overall heritable mutation rate
(individual), % median (range)†Total n Survival, % Fertile, n
Germ-line
mutants, n (%)*
U6b Short 78 36 46.2 28 6 (21.4) 3.2 (1.1–64.6)
U6a Short 68 17 25.0 5 4 (80.0) 2.1 (1.2–6.8)
nos-mini Short 56 9 16.1 7 0 0
U6b Long 64 18 28.1 13 4 (30.8) 1.7 (1.5–10.0)
*The percentage of germ-line mutants was calculated as the proportion of fertile G0 flies that gave rise to white-eyed progeny.
†The overall heritable mutation rate was calculated as the number of white-eyed F1s divided by the number of all F1s observed. Mutation rates for each G0 fly
that generated white-eyed progeny are shown in parentheses and are calculated as the number of white-eyed F1s divided by the total F1s observed from
a single G0 fly.
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16, 20). Gratz et al. (16) coinjected two DNA plasmids, one
encoding Cas9 and the other encoding a single sgRNA targeting
the X-linked yellow (y) gene. In that study, Cas9 was expressed
under the control of the hsp70 promoter and 3′ UTR, and the
sgRNA was under the control of the snRNA U6b promoter. The
system was effective in generating somatic patches of yellow
tissues in 62% of injected G0 males. Furthermore, germ-line
transmission, as detected by the presence of at least one yellow
offspring, was observed in 6.4% of the G0 males. The overall
germ-line transmission rate (i.e., the number of yellow offspring
as a percentage of all progeny) was 0.25%. Gratz et al. (16) also
showed that when Cas9 was coinjected with a pair of sgRNAs
designed to work together to precisely delete y, 25% of the
injected males produced yellow progeny, with an overall germ-
line transmission rate of 1.4%.
A different approach was taken by Bassett et al. (14) and Yu
et al. (20), who injected fly embryos with in vitro transcripts
encoding Cas9 and sgRNA. Basset et al. (14) injected a mix of
Cas9 mRNA and sgRNA transcripts targeting either y or w. In
their system, both Cas9 and sgRNA were under the control of
a bacterial T7 promoter, and a poly-A tail was added post-
transcriptionally to the in vitro-transcribed Cas9 mRNA. This
system was more effective than the system reported by Gratz
et al. (16) at generating somatic mosaics, with 86% of the
injected G0 males exhibiting patches of yellow tissues; however,
the adult survival rate was only 3%. For the w gene, 25% of
injected G0 males had visible phenotypes, and the survival rate
was <3%. Although the authors reported that reducing the
concentration of mRNA increased the survival rate from 3% to
11%, the proportion of mosaic adults decreased dramatically,
from 86% to 10%. Furthermore, germ-line transmission, as de-
tected by the presence of at least one yellow offspring, was ob-
served in 58% of the G0 males, and 34.5% of all offspring
contained a mutation in the y gene.
Similarly, Yu et al. (20) injected the in vitro synthesized Cas9
mRNA and sgRNA, and reported a similar efficiency of muta-
genesis. In that study, the Cas9 mRNA was transcribed under the
control of the Sp6 promoter, and transcription of the sgRNA was
under the control of the T7 promoter.
Compared with the foregoing methods, the approach that we
describe herein has three key advantages. First, we did not ob-
serve any visible phenotypes in G0-injected flies, most likely
because control by the nos promoter limits Cas9 expression to
the germ cells. Importantly, the absence of somatic events will
circumvent the potentially deleterious effects of inducing
mutations into the somatic tissues of G0 animals when genes
required for cell viability or developmental processes are tar-
geted. Second, the frequency of germ-line transmission that we
observed is much higher than that reported for other methods.
Injection of a single sgRNA plasmid into Cas9 transgenic flies
A
B C
D
E
Fig. 2. Testing the optimized Drosophila nos-
Cas9/sgRNA system on the white locus. (A) Sche-
matic of two sgRNAs targeting the white locus,
with the 20-nt target sequence underscored and
PAM in bold type. Gray boxes represent exons. w1
sgRNA targets the first exon, and w2 targets the
second. (B) RT-PCR results confirming the expres-
sion of Cas9 in {nos-Cas9}attP40 and {nos-Cas9}
attP2 embryos, with actin 5C as an internal con-
trol. (C and D) Representative sequencing results
showing the indel mutations generated in this
study, with w1 sgRNA (C) and w2 sgRNA (D). (E)
Schematic showing the defined deletion gener-
ated by using w1 and w2 sgRNAs, along with
representative sequencing results showing the
break points of the deletions generated. The ge-
nomic sequence between the sgRNA target sites is
not shown. In C–E, the targeted genomic DNA
sequence is underscored, and the NGG PAM se-
quence is in bold type. Dashed lines represent
the locations of genomic deletions detected by
sequencing.
Table 3. Heritable mutation rates using transgenic {nos-Cas9}attP2 flies and sgRNA plasmid
sgRNA Embryos, n
G0 adults
Overall heritable mutation
rate (individual), %, median
(range)†Total n Survival, % Fertile, n
Germ-line
mutants, n (%)*
w1 61 16 26.2 13 13 (100.0) 42.9 (3.3–100)
w2 65 17 26.2 17 15 (88.2) 12.4 (1.1–58.3)
w1 + w2 71 21 29.6 12 11 (91.7) 74.2 (13.6–100)
*The percentage of germ-line mutants was calculated as the proportion of fertile G0 flies that gave rise to white-eyed progeny.
†The overall heritable mutation rate was calculated as the number of white-eyed F1s divided by the number of all F1s observed. Mutation rates for each G0 fly
that generated white-eyed progeny are shown in parentheses and were calculated as the number of white-eyed F1s divided by the total number of F1s
observed from a single G0 fly.
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produced a G0 rate of 93.3% (28 of 30) and an overall heritable
mutation rate as high as 42.9%. In addition, we found that in-
jection of a pair of sgRNAs can lead to the generation of defined
genome deletion of the region between the targets, with
a further improved overall heritable mutation rate (74.2%;
Table 3). Indeed, after injection of two sgRNAs, 91.7% (11 of
12) of fertile G0 flies produced F1 mutants. Among all mutant-
producing fertile G0 flies, 18.2% (2 of 11) produced mutant
progeny at a rate of 50–80%, 18.2% (2 of 11) did so at a rate of
80–100%, and 54.5% (6 of 11) generated only mutant progeny
(100%). We found a much higher survival rate of G0 flies
(26.2%) after injection of only w1 sgRNA plasmid. This rate
compares favorably with a previously reported 3% survival
obtained after direct injection of Cas9 mRNA and sgRNA
(14). At 81%, the G0 fertility rate of the optimized system was
also higher than the 72% rate found with the Cas9 mRNA
method. Third, the direct material costs associated with our method
are roughly 10–20% of those associated with direct injection of Cas9
mRNA, because our approach avoids the need for in vitro tran-
scription. In addition, because of its high efficiency and low lethality,
our approach requires microinjection of only approximately 20
embryos (roughly 1/15th of that in previously reported methods)
to achieve the same level of mutagenesis, further contributing to
the cost-effectiveness of our approach.
To be useful, a genome engineering technique must be spe-
cific. Experience with other mutagenesis methods and previous
reports with CRISPRs have taught us that off-targets are a major
concern. Previous in vitro studies have indicated that sgRNA/
Cas9 specificity extends past a 7- to 12-bp seed sequence and that
up to five mismatches are tolerated depending on their posi-
tions along the sgRNA (23, 24). Using various methods, we
detected no off-targets in either CDS or intergenic regions (Fig.
S1), suggesting that the Cas9 protein is expressed at appro-
priate levels in the transgenic animals, and that specificity can be
improved by designing sgRNAs to avoid highly similar off-
targets.
Several CRISPR Web tools are available online; however,
these do not provide much information about potential off-
targets. We have developed a user interface that allows the
community to query all relevant sgRNA designs by gene iden-
tifier (gene symbol, CG number, or FBgn) or genome coor-
dinates, and also to view all corresponding sgRNA designs on
a genome browser (Fig. S2). To facilitate the use of sgRNAs in
Drosophila, we have established a freely available online re-
source of precomputed sgRNAs (www.flyrnai.org/crispr) (Table
4). The designs are organized into subset “tracks” based on off-
target potential. Moreover, a detail page that includes a sum-
mary list of potential off-targets can be viewed for each design.
Our simplified Cas9/sgRNA system will facilitate the genera-
tion of large mutant collections, including both loss-of-function
indel mutations and defined deletions. Fig. S3 shows a flowchart
designed to expedite the production of such collections in a semi-
high-throughput manner. In addition to generation of deletions
via NHEJ after production of DSB, based on a previous report
(16), we expect that using our system with a donor DNA will
facilitate HR-mediated knock-in approaches, such as the in-
troduction of visible markers. This would expand the applications
of our approach, including easier mutation identification (e.g.,
after knock-in of a marker), introduction of site-directed muta-
genesis in endogenous loci, and in-frame insertion of ectopic
tags into genomic sequence to detect gene expression patterns.
Materials and Methods
Cas9 and sgRNA Plasmid Design. To express Cas9 in Drosophila germ cells, we
constructed a nos cassette plasmid containing approximately 700 base pairs of
the nos promoter, the nos 5′ UTR, and the nos 3′ UTR. The attB donor se-
quence and a vermillion+ marker were also included in the nos cassette plas-
mid. The Cas9 coding sequence was then excised from pcDNA3.1-Cas9 (25) and
cloned into the XbaI and AvrII restriction sites of the nos cassette plasmid.
Two sgRNA scaffolds were designed: a short scaffold, as described by Mali
et al. (10), and a long scaffold with 10 extra base pairs between the crRNA
and the tracrRNA modules (Fig. 1C). To express sgRNA in vivo, we selected
three different regulatory sequences: U6a (CR31379) and U6b (CR32867) (26,
27), both of which direct transcription of Drosophila U6 snRNAs, and nos-
mini, which contains the nos promoter and a minimal 5′ UTR (28, 29). We
used the 404-bp upstream and 93-bp downstream regulatory sequences of
U6a to construct U6a-sgRNA-short and U6a-sgRNA-long. Similarly, we used
the 400-bp upstream and 95-bp downstream regulatory sequences of U6b to
construct U6b-sgRNA-short and U6b-sgRNA-long. The nos 700-bp promoter,
80-bp minimal 5′ UTR, and 900-bp 3′ UTR were used to construct nos-
minisgRNA-short and nos-minisgRNA-long. In all six versions of the sgRNA
plasmid, the 20-bp target sequence is inserted into two BbsI sites at the be-
ginning of the sgRNA scaffold. A 680-bp fragment was placed between the
BbsI sites as a marker for detecting incomplete enzyme digestion. The se-
quence of the nos-Cas9 plasmid is shown in Fig. S4, and partial sequences of
the six different versions of the sgRNA constructs used are shown in Fig. S5.
Fly Stocks. All flies were cultured on standard cornmeal food at 25 °C. The
{nos-Cas9}attP40 and {nos-Cas9}attP2 fly stocks were established according
to a previously described protocol (30). In brief, nos-Cas9 was inserted into
attP40 on the second chromosome or attP2 on the third chromosome
by microinjection into y[1] sc[1] v[1] P{y[+t7.7]=nos-phiC31\int.NLS}X; P{y[+
t7.7]=CaryP}attP40 or y[1] sc[1] v[1] P{y[+t7.7]=nos-phiC31\int.NLS}X; P{y[+
t7.7]=CaryP}attP2 fly embryos, respectively, followed by screening for the
CAGGAGCTATTAATTCGCGGAGG w1 sgRNA target site 
GAAGGGGGATTACTTCGCGGAGG w1 potential off-target site: Mo25 
AGTGAAATAATAATTCGCGGGGG w1 potential off-target site: CG6428 
GTTATCGGTTCAATTCGCGGTGG w1 potential off-target site: CTPsyn
GAATATGTTTTAATTCGCGGCGG w1 potential off-target site: pyd (intron) 
CATCAATATTTAATTCGCGGGGG w1 potential off-target site: His2Av (intron)
B 
TAGTTGGCCGCTCCCTGAACCGG w2 sgRNA target site 
TAGGCATCCAGTCCCTGAACCGG w2 potential off-target site: Nrg
TGTTGGTATGTTCCCTGAACCGG w2 potential off-target site: Vm26Ac 
GGCTTTGAAGATCCCTGAACGGG w2 potential off-target site: CTPsyn
TCTGGAACTTCTCCCTGAACAGG w2 potential off-target site: CG1907 
GCGGCTGTAGCTCCCTGAACAGG w2 potential off-target site: fru (intron) 
A                                                    
NGG:PAM N:mismatch
Fig. 3. No off-targets were detected using the optimized Drosophila Cas9/
sgRNA system to generate heritable mutations. (A and B) Potential off-target
sites for w1 sgRNA (A) and w2 sgRNA (B). Genomic regions that have at least
11-nt homology to the sgRNA seed region and a neighboring PAM sequence
were sequenced from F1 white-eyed flies generated by the optimized sys-
tem. Mismatches between the potential off-targets and the targeted region
are underscored. The PAM sequences are in bold type.
Table 4. Statistics for the sgRNA resource
CRISPR category All CRISPRs No off-target No off-target in CDS regions Off-target in CDS regions
All CRISPRs 7,566,724 300,034 2,894,160 4,372,530
CRISPRs target intergenic region 2,110,255 76,182 907,314 1,126,759
CRISPRs target gene region 5,456,469 223,852 1,985,158 3,247,459
CRISPRs target intron region 2,786,650 95,393 1,231,172 1,460,085
CRISPRs target exon region 2,669,819 128,459 753,986 1,787,374
CRISPRs target exon-CDS region 2,107,960 104,892 506,998 1,496,070
CRISPRs target exon-noncoding region 561,859 23,567 246,988 291,304
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vermillion+ marker present in the nos-Cas9 plasmid. Canton-S and y[1]w
[67c23] flies were used.
Genomic DNA Extraction. Fly genomic DNAwas purified via phenol-chloroform
extraction. Single flies were homogenized in 400 μL of lysis buffer (1X PBS,
0.2% SDS, and 200 μg/mL proteinase K; Roche) and incubated at 50 °C for 1 h,
followed by extraction in 400 μL of phenol-chloroform. The mixture was then
centrifuged at 21,000 X g for 20 min at 4 °C, after which the supernatant was
transferred to a new tube. An equal volume of isopropanol was added, and
the tube was vortexed thoroughly. The mixture was then kept at −20 °C for at
least 1 h, followed by centrifugation at 21,000 X g for 20 min at 4 °C. The
supernatant was removed, and the pellet was washed with 500 μL of 75%
ethanol, followed by centrifugation at 21,000 X g for 5 min at 4 °C. Finally, the
pellet was dried for 10 min and resuspended in 30 μL of DNase-free water.
Embryo Injection. Plasmid DNA was microinjected into Drosophila embryos
following standard protocols. To mutagenize flies with Cas9 and sgRNA, the
nos-Cas9 plasmid (250 ng/μL) and sgRNA plasmid (250 ng/μL) were coinjected
as a mixture. For coinjection of the plasmids, the injection solution consisted
of 250 ng/μL of the nos-Cas9 plasmid and 250 ng/μL of each sgRNA plasmid.
When using transgenic Cas9 flies, a single sgRNA plasmid at 250 ng/μL was
injected or two sgRNA plasmids at 250 ng/μL each were coinjected.
Screening of Mutations. To score for germ-line mutations, all G0 adult flies
that developed from injected embryos were crossed to y[1]w[67c23] flies. The
F1 progeny were then screened for white eye color over a 6-d period. If the
G0 fly was a female, then all progeny were screened. If the G0 fly was
a male, then only female progeny were screened. Individual heritable muta-
tion rates were calculated for each single G0 as the number of mutant F1s out
of the number of screened progeny. The overall heritable mutation rate was
calculated as the number of all mutant F1s out of the number of all screened
progeny for a given sgRNA target. Mutagenesis events were confirmed by
sequence analysis of F1 adults; the detection primers are listed in Table S2.
Off-Target Analysis. To investigate the possibility of off-target cleavage by
Cas9/sgRNA, we searched the fly genome for potential off-targets containing
a match to the sgRNA sequence of at least 11 nt followed by the PAM se-
quence, as well as a match of 13 or 14 nt but without a neighboring PAM
sequence. Primers flanking the potential off-targets were used to PCR-
amplify these regions for analysis by HRMA and sequencing. For sequencing
analysis, genomic DNA from a single fly was used as template, and the de-
fined DNA fragment was amplified by specific primers carrying EcoRI and
XbaI (Table S2). The PCR products can be directly sequenced by one of the
primers or cloned into the linearized VALIUM1 vector (30) by the same set of
restriction enzymes, and then sequenced by specific primers (Table S2).
HRMA. For both on-target and off-target HRMA assays, PCR was performed
using specific primers (Table S2, off-target sequencing primers) to amplify
regions surrounding the target site from genomic DNA isolated from either
injected embryos (for on-target analysis) or F1 adults (for off-target analysis).
PCR products were diluted 1:500,000 before a second round of PCR using
nested primers (Table S2, off-target HRM primers) to generate short
amplicons (70–150 bp) including the target sites. Melting curves were gen-
erated by heating from 55 °C to 95 °C and measuring fluorescence in the
presence of Evagreen DNA dye at increments of 0.1 °C. Both amplification
and melt curve steps were performed using a BioRad CFX Real-Time System
qPCR machine and BioRad Precision Melt Supermix. Genomic DNA isolated
from the uninjected parent strain (y[1] sc[1] v[1] P{y[+t7.7]=nos-phiC31\int.
NLS}X; P{y[+t7.7]=CaryP}attP2) was used to generate control samples. HRMA
data were analyzed to identify melt curves that differed significantly from
controls using custom scripts that will be reported in detail separately. The
HRMA analysis data are provided in Table S1.
RT-PCR. Total RNA was isolated from 0- to 1-h Drosophila embryos using the
AxyPrep Multisource Total RNA MiniPrep Kit (Axygen). A total of 3 μg RNA
was used to create cDNA, using the GoldScript cDNA Kit (Invitrogen)
according to the manufacturer’s protocol, followed by PCR to amplify the
target sequence. The Actin 5C gene served as an internal control. Primer
sequences are listed in Table S2.
Assembly of Online Resource. A Perl module was developed in-house to
identify all possible CRISPR sequences from both strands of genome
sequences downloaded from FlyBase release 5.52 (July 16, 2013). The BLAST
program was used to identify all possible off-target sites, and a second Perl
modulewas developed in-house to annotate on-target and off-target sites, as
well as to format GFF3 files to upload genome browse. JBrowse was used and
configured to display all CRISPR designs.
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